Pulse Biosciences, Inc. (PLSE) Cash Flow Statement
Pulse Biosciences, Inc. (PLSE) generated -$61.1M of operating cash flow over the twelve months to 2026-06-30, spent $290000 on capital expenditure and had free cash flow of -$61.4M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
PLSEPulse Biosciences, Inc.Follow PLSE — free
—
Price chart with a free account
- Market cap
- 3.8B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 16 Nov, in 23 days
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|
| Operating cash flow | -54.1 | -47.0 | -54.1 | -61.1 | |
| Capital expenditure | 0.4 | 0.4 | 0.3 | -0.3 | |
| Free cash flow | -54.5 | -47.4 | -54.4 | -61.4 | |
| Stock-based compensation | 14.6 | 5.2 | 21.5 | — |
USD millions · SEC XBRL
Pulse Biosciences, Inc. — questions
- What is Pulse Biosciences, Inc.'s operating cash flow?
- -$61.1M over the twelve months to 2026-06-30.
- How much does Pulse Biosciences, Inc. spend on capital expenditure?
- $290000 over the twelve months to 2026-06-30.
- What is Pulse Biosciences, Inc.'s free cash flow?
- -$61.4M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Pulse Biosciences, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.